HRES 1434 United States House · 117th Congress

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

Summary
This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act. The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.
Bill status passed 3 of 5 stages cleared
Introduction
Oct 2022
Committee Review
Oct 2022
House Passage
Dec 2022
Senate Passage
President
Introduced Oct 14, 2022 Last action Dec 21, 2022
Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
5
Key actions
2
Committee
2
Dec 21, 2022
Lower · Passed
Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
lower
Dec 21, 2022
Lower · Passed
Passed/agreed to in House: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
lower
Oct 17, 2022
Committee
Referred to the Subcommittee on Health.
lower
Oct 14, 2022
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Oct 14, 2022
Introduced
Introduced in House
lower
1 primary · 38 co-sponsors

Sponsors